Targeted binding agents directed to uPAR and uses thereof

Details for Australian Patent Application No. 2011204792 (hide)

Owner AstraZeneca AB

Inventors Elvin, Paul; Emery, Stephen Charles; Zhao, Qing

Agent Davies Collison Cave

Pub. Number AU-A-2011204792

Parent 2007238809

Filing date 15 July 2011

Wipo publication date 4 August 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

4 August 2011 Application Open to Public Inspection

  Published as AU-A-2011204792

4 August 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011204793-Golf balls including multiple dimple types and/or multiple layers of different hardnesses

2011204791-Novel acylalkylisethionate esters and applications in consumer products